Clinical Trial

Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV Patients

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This trial employed a multicenter, randomized, double-blind, parallel, placebo-controlled design to evaluate the preventive effect of BPR-101 capsules combined with metronidazole on the recurrence of BV, as well as the cure rate and safety.
Trial Details
NCT Number NCT07483671
Lead Sponsor Chengdu Syncor Pharmaceutical Co., Ltd.
Conditions Bacterial Vaginosis
Enrollment 80 participants
Start Date 2026-04-15
Primary Completion 2027-01-24 (estimated)
Study Completion 2027-01-24 (estimated)
Updated on ClinicalTrials.gov 2026-03-19